Ten years' disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy A case report and literature review

被引:2
|
作者
Zhang, Jue [1 ]
Mei, Liejun [2 ]
Wang, Fubing [3 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan 430071, Peoples R China
基金
北京市自然科学基金;
关键词
advanced ovarian cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; HIPEC; PACLITAXEL; CISPLATIN;
D O I
10.1097/MD.0000000000023404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. Patient concerns: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. Diagnoses: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. Interventions: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. Outcomes: Till March 9, 2020, the patient has disease-free survival over 10 years. Lessons: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis
    Wang, Yizi
    Ren, Fang
    Chen, Peng
    Liu, Shuang
    Song, Zixuan
    Ma, Xiaoxin
    EJSO, 2019, 45 (03): : 301 - 309
  • [42] The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
    Zhang, Guyu
    Zhu, Yimin
    Liu, Chongdong
    Chao, Guangming
    Cui, Ran
    Zhang, Zhenyu
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [43] The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
    Guyu Zhang
    Yimin Zhu
    Chongdong Liu
    Guangming Chao
    Ran Cui
    Zhenyu Zhang
    Journal of Ovarian Research, 12
  • [44] A rare case of recurrent epidermoid anal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-case report
    Pravong, Vera
    Brind'Amour, Alexandre
    Sideris, Lucas
    Dube, Pierre
    Tremblay, Jean-Francois
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [45] ASO Visual Abstract: Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer
    Lisa Frankinet
    Aditi Bhatt
    Vincent Alcazer
    Jean-Marc Classe
    Jean-Marc Bereder
    Pierre Meeus
    Christophe Pomel
    Francois Mithieux
    Karine Abboud
    Romauld Wermert
    Vincent Lavoue
    Frederic Marchal
    Olivier Glehen
    Naoual Bakrin
    Annals of Surgical Oncology, 2023, 30 : 3302 - 3303
  • [46] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience
    Pavlov, Maja J.
    Ceranic, Miljan S.
    Latincic, Stojan M.
    Sabljak, Predrag V.
    Kecmanovic, Dragutin M.
    Sugarbaker, Paul H.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2018, 34 (05) : 564 - 569
  • [47] Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis
    Torun, Bahar Canbay
    Glehen, Olivier
    Kepenekian, Vahan
    Sardi, Armando
    Arjona-Sanchez, Alvaro
    Yonemura, Yutaka
    Barat, Shoma
    Morris, David
    Spiliotis, John
    Coccolini, Federico
    Sommariva, Antonio
    Bartos, Adrian
    Raza, Sayyed
    Vander Speteen, Kurt
    Akin, Levhi
    Irez, Tulay
    Canbay, Emel
    EJSO, 2023, 49 (08): : 1489 - 1494
  • [48] The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent advanced ovarian cancer: a prospective study
    Spiliotis, J.
    Vaxevanidou, A.
    Sergouniotis, F.
    Lambropoulou, E.
    Datsis, A.
    Christopoulou, A.
    JOURNAL OF BUON, 2011, 16 (01): : 74 - 79
  • [49] Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer
    Bai, Yun
    Du, Ye
    Ye, Pengpeng
    Luo, Yang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] Ninety-day readmissions after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
    Kovalik, Vladislav
    King, Mary Caitlin
    Zuniga, Luis Felipe Falla
    Iugai, Sergei
    Pawlikowski, Kathleen
    Nieroda, Carol
    Diaz-Montes, Teresa
    Gushchin, Vadim
    Sardi, Armando
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S422 - S423